The Global Hernia Mesh Devices Market wasvalued at US$ 4.5 Bn in 2021 andis expected to reach US$ 6.5 Bnby 2032, finds Future Market Insights (FMI) in a recent market survey. As per
the findings of the report, Inguinal Hernia will continue to constitute 80% of all hernias. They are the mostcommon type of hernia and it is 10Xmore common in men than in women. This illustrates high hernia mesh devices
revenue growth through them.
Synthetic Hernia Mesh will be the Most used Mesh forSurgery throughout the Analysis Period
According to FDA, 90%of Hernia surgeries are using synthetic mesh devices. The robust supply chain,
availability of raw materials, and relatively less cost are the key reasons
behind the dominance of synthetic mesh in the market. The number of hernia
operations in China reached 1 Mn in 2015 and is increasing by 20-30 % each following year. Herniamesh device revenue in China is expected to reach US$ 431.1 Mn valuations by 2032.
North America will see continued revenue growth in HerniaMesh Market throughout the Analysis Period
North America is expected to grow at 3.4% CAGR in the next decade. Reimbursement for hernia mesh isfavourable in North America, which encourages patients to choose laparoscopic
surgery. Patients can easily obtain comprehensive payment codes and ratios made
public by governments and industry stakeholders. Furthermore, technological
advancements and the development and adoption of new goods, such as TELA Bio,
are propelling the entire market forward in terms of revenue.
“Despite the 90% dominance of synthetic mesh inthe Hernia Mesh device market, the biological mesh-based hernia devices can
reap significant market revenue in the forthcoming years” comments an analyst at Future Market Insights.
Hernia Mesh Devices Market: Competition Insights
Most of the key players in hernia mesh devices market havebeen focusing on obtaining approvals from regulatory authorities. The key
companies operating in the Hernia Mesh Devices market include Medtronic plc,
Ethicon, and W. L. Gore and Associates, Inc., Atrium Medical Technologies, B.
Braun Melsungen AG, PRIMEQUAL SA, Becton, Dickinson, and Company, Deep Blue
Medical Inc., Dipromed Srl, BioCer Entwicklungs-GmbH, Betatech Medical,
Sinolinks Medical Innovation, Inc, Aspide Medical S.A.S., Meril Life Sciences
Pvt. Ltd., Herniamesh Srl., Changzhou Medical Equipment General Factory Co.,
Ltd, Gem Srl, SAMYANG HOLDING CORPORATION, Katsan Katgut Sanayi Ve Ticaret
Anonim Sirketi, Novus Scientific
AB.
- The key recentdevelopments of Hernia Mesh Devices manufacturers are as follows:
- In Mar 2020, Novus Scientific AB received FDA approval for TIGR Matrix
Surgical Mesh indicated for use in procedures involving soft tissue
repairs, such as for the repair of hernias or other soft tissue-related
defects. - In Jul 2020, Becton, Dickinson, and Company received FDA clearance for 3DMax
MID Anatomical Mesh indicated for use in the reinforcement of soft tissue,
and repair of inguinal hernias. - In Aug 2020, Deep Blue Medical Inc., secured the clearance of the U.S. FDA
for commencing the sale of its new hernia mesh product. The promising
sales opportunities of the product have led the company to recently
announce its equity of US$ 3.4 Mn in the company by investors.
Key Segments:
Key Segments Coveredin Hernia Mesh Devices Market Survey
- Hernia Mesh DevicesMarket by Mesh Type:
- Biological Mesh
- Synthetic Mesh
- Hernia Mesh DevicesMarket by Hernia Type:
- Inguinal Hernia
- Incisional Hernia
- Femoral Hernia
- Others
- Hernia Mesh DevicesMarket by Region:
- North America Hernia Mesh Devices Market
- Latin America Hernia Mesh Devices Market
- Europe Hernia Mesh Devices Market
- South Asia Hernia Mesh Devices Market
- East Asia Hernia Mesh Devices Market
- Oceania Hernia Mesh Devices Market
- Middle East & Africa Hernia Mesh Devices Market
Information Source:
